Navigation Links
The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings

Conference Call and Webcast Scheduled for March 7, 2008 at 2:00 pm ET

MISSION VIEJO, Calif., March 6 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services and assisted living companies, today reported results for the fourth quarter and the fiscal year ended 2007.
(Logo: )

Highlights of the Fourth Quarter Include:

-- Total revenue was $109.0 million, up 11.8% from the prior year

-- Organic revenue grew 5.0%

-- Sequential revenue grew 4.7% over Q3, an acceleration from Q3 2007

growth of 3.8%

-- Skilled revenue was 42.8%, an increase of 110 basis points


-- EBITDAR was $16.8 million, up 11.7% vs. a year ago and up 20.9%


-- Net income was $6.2 million, up 16.5% over Q4 2006 and up 39.5%


Operating Results

For the quarter ended December 31, 2007, total revenue was $109.0 million, up 11.8% compared to $97.5 million for the prior year quarter, and up 4.7% sequentially. On a same-facility basis, total revenue in the fourth quarter of 2007 increased 5.0% from the comparable quarter in the prior year. In addition, revenue generated by facilities acquired subsequent to October 1, 2006 increased by $6.7 million.

The company reported fourth quarter 2007 net income of $6.2 million or $0.32 per diluted share, compared to $5.4 million or $0.31 per diluted share for the fourth quarter of 2006.

Commenting on the results, Ensign President and Chief Executive Officer Christopher Christensen said, "We are pleased with our fourth quarter 2007 performance. We believe that these results represent a strong validation of Ensign's business model and demonstrate robust momentum heading into 2008."

For the year ended December 31, 2007, total net revenue was $411.3 million, up 14.7% compared to $358.6 million for the fiscal year 2006. On a same-facility basis, total revenue for the year ended 2007 increased 2.3% from the comparable period in 2006. In addition, revenue generated by facilities acquired in 2006 and 2007 increased $45.0 million.

The company reported net income for the year ended 2007 of $20.5 million or $1.17 per diluted share compared to $22.5 million or $1.34 per diluted share for the year ended 2006. EBITDAR for the year ended December 31, 2007 was $60.4 million as compared to EBITDAR of $59.5 million for the comparable period in 2006. EBITDAR is a non-GAAP financial measure. A discussion of the company's use of this non-GAAP financial measure is set forth below, and a reconciliation of net income to EBITDAR for the fourth quarter 2007 and 2006 and the year ended December 31, 2007 and 2006, respectively, appears in the financial data portion of this release.

More complete information is contained in the Company's 10-K, which was filed with the SEC today and can be viewed on the Company's website at

Recent Highlights

On February 21, 2008, Ensign operating subsidiaries expanded their credit facility with GE Healthcare Financial Services to $50.0 million and extended it for an additional five years. In addition to funding working capital, the credit facility also supports Ensign's growth strategy of acquiring underperforming facilities that cannot typically be financed with conventional acquisition loans. The new loan carries borrowing options that allow Ensign to draw short-term revolving credit borrowings, or one to six month LIBOR-based fixed-rate borrowings, at Ensign's option.

On February 1, 2008, Covey C. Christensen became the President of The Flagstone Group, Inc., the Ensign subsidiary responsible for supporting fifteen Southern California operating locations located throughout Los Angeles, Orange and San Diego Counties. He replaced Christopher Christensen, who had been doing double duty as both Ensign's CEO and Flagstone's interim President since May 2007. The Company's intention to install a permanent leader for Flagstone was previously disclosed in Ensign's recent Registration Statement on Form S-1 and Form 10-Q for the third quarter of 2007.

Ensign also recently announced that its Waverly Park skilled nursing facility in Tucson, Arizona has successfully graduated from the Special Focus Facility Program established by the Centers for Medicare and Medicaid Services (CMS). The 200-bed skilled nursing facility was in bankruptcy when Ensign acquired it, and was placed on Special Focus status by CMS in 2005 based on its long history of what CMS calls "yo-yo" compliance. The challenging clinical turnaround concluded when the facility passed its final Special Focus inspection in November 2007 with a nearly unheard-of one-deficiency survey report. Ensign now has two additional facilities that have been named to the Special Focus Facility list. CMS and state regulators selected the two based on their last three years of regulatory history, even though Ensign acquired them much more recently. One of the facilities, Mt. Ogden Rehab & Care Center in Ogden, Utah, has already had one successful survey by state regulators since Ensign took it over.

2008 Guidance

Ensign currently expects revenue of $450.0 million to $454.0 million and fully diluted earnings per share between $1.27 and $1.32 for fiscal year 2008. This guidance assumes, among other things, no additional acquisitions or dispositions, a continued stable Medicare reimbursement environment and no net changes in the Medicaid environment.

Conference Call

A live webcast will be held on Friday, March 7, 2008, at 11:00 a.m. Pacific Time (2:00 p.m. Eastern Time) to discuss Ensign's fourth quarter and fiscal year 2007 financial results. To listen to the webcast, or to view any financial or other statistical information required by SEC Regulation G, please visit the Investors section of the Ensign website at The webcast will be recorded, and will be available for replay via the website until 5:00 p.m. (Pacific Time) on Monday, March 17, 2008.

About Ensign(TM)

The Ensign Group, Inc.'s operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, physical, occupational and speech therapies, and other rehabilitative and healthcare services for both long-term residents and short-stay rehabilitation patients, at 61 facilities located in California, Arizona, Texas, Washington, Utah and Idaho. Each of these facilities is operated by a separate, wholly-owned independent operating subsidiary that has its own management, employees and assets. The use of "we," "us," "our" and similar words in this release is not meant to imply that these facilities are operated by the same entity. More information about Ensign is available at

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management's current expectations, assumptions and beliefs about our business, financial performance, operating results, the industry in which we operate and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding our growth prospects, future operating and financial performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause our actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to our business, our industry and our common stock and include: reduced prices and reimbursement rates for our services; our ability to acquire, develop, manage or improve facilities, our ability to manage our increasing borrowing costs as we incur additional indebtedness to fund the acquisition and development of facilities; our ability to access capital on a cost-effective basis to continue to successfully implement our growth strategy; our operating margins and profitability could suffer if we are unable to grow and manage effectively our increasing number of facilities; competition from other companies in the acquisition, development and operation of facilities; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit our business operations, require us to incur significant expenditures or limit our ability to relocate our facilities if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review our periodic filings with the Securities and Exchange Commission, including our Form 10-K, which was filed today, for a more complete discussion of the risks and other factors that could affect Ensign's business, prospects and any forward-looking statements. Except as required by the federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Consolidated Statements of Income

(in thousands, except per share data)

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

Revenue $108,979 $97,509 $411,318 $358,574


Cost of services

(exclusive of facility

rent and depreciation

and amortization shown

separately below) 87,837 78,705 335,014 284,847

Facility rent-cost of

services 4,164 4,144 16,675 16,404

General and

administrative expense 4,307 3,739 15,945 14,210

Depreciation and

amortization 1,962 1,360 6,966 4,221

Total expenses 98,270 87,948 374,600 319,682

Income from operations 10,709 9,561 36,718 38,892

Other income (expense):

Interest expense (1,206) (919) (4,844) (2,990)

Interest income 584 272 1,558 772

Other expense, net (622) (647) (3,286) (2,218)

Income before provision

for income taxes 10,087 8,914 33,432 36,674

Provision for income

taxes 3,858 3,564 12,905 14,125

Net income $6,229 $5,350 $20,527 $22,549

Net income per share:

Basic $0.35 $0.39 $1.39 $1.66

Diluted $0.32 $0.31 $1.17 $1.34

Weighted average common

shares outstanding:

Basic 17,566 13,393 14,497 13,366

Diluted 19,204 16,984 17,470 16,823

Consolidated Balance Sheets

(in thousands)

December 31,

2007 2006


Cash and cash equivalents $51,732 $25,491

Other current assets 68,631 58,314

Total current assets 120,363 83,805

Property and equipment, net 124,861 87,133

Other assets 22,165 19,593

Total assets $267,389 $190,531

Liabilities and stockholders' equity

Current liabilities:

Current liabilities, excluding current

maturities of long-term debt $54,401 $54,583

Current maturities of long-term debt 2,993 941

Total current liabilities 57,394 55,524

Long-term debt-less current maturities 60,577 63,587

Other long-term liabilities 19,741 17,548

Series A redeemable convertible preferred stock -- 2,725

Total Stockholders' equity 129,677 51,147

Total liabilities and stockholders' equity $267,389 $190,531

Reconciliation of Net Income to EBITDAR

(in thousands)

Three Months Ended

December 31, Year Ended December 31,

2007 2006 2007 2006

Net income $6,229 $5,350 $20,527 $22,549

Interest expense, net 622 647 3,286 2,218

Provision for income taxes

3,858 3,564 12,905 14,125

Depreciation and amortization 1,962 1,360 6,966 4,221

Facility rent -- cost of

services 4,164 4,144 16,675 16,404

EBITDAR $16,835 $15,065 $60,359 $59,517

Discussion of Non-GAAP Financial Measures

EBITDAR consists of net income before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, and (d) facility rent-cost of services. The Company believes that the presentation of EBITDAR provides important supplemental information to management and investors to evaluate the Company's operating performance. This non-GAAP financial measure should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the Company believes that this non-GAAP measure provides useful information to investors, the specific manner in which management uses this measure, and some of the limitations associated with the use of this measure, please refer to the Company's Report on Form 10-K filed today with the SEC. The Form 10-K is available on the SEC's website at or under the "Financial Information" link of the Investor Relations section of Ensign's website.

SOURCE The Ensign Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Ensign Group, Inc. to Announce Third Quarter 2007 Financial Results
2. The Ensign Group, Inc. Acquires Assets of Three Previously Leased Facilities
3. The Ensign Group, Inc. Reports Third Quarter 2007 Earnings
4. The Ensign Group, Inc. Announces the Appointment of Covey C. Christensen as President of Its Flagstone Subsidiary
5. The Ensign Group Successfully Graduates Troubled Nursing Home from CMS Special Focus Facility Program
6. The Ensign Group Establishes $50 Million Credit Facility with GE Healthcare Financial Services
7. The Ensign Groups Year-End Conference Call Scheduled for Friday, March 7, 2008
8. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
11. Nyer Medical Group, Inc. Reports EPS of $.02 on Record Revenues of $69.9 Million for Fiscal Year Ended 2007
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... An ... way to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC ... and dispense prescription medications. In doing so, it could help to prevent potential ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a ... component is distributed nationally, through a vast social media strategy and across a ...
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with ... the 2016 Building Better Radiology Marketing Programs meeting will showcase some ... March 6, 2016, at Caesars Palace in Las Vegas with a pre-conference session ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you ... for not only fulfilling the needs of advisers and clients but going above ... and providing top-tier customer service. However, there's always room for improvement, which is ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... ATLANTA , Nov. 25, 2015 ... the first federal bellwether trial against Wright Medical ... relating to their Conserve metal-on-metal hip implant device, ... Christiansen.  Following a two week trial and three ... Conserve metal-on-metal hip device was defectively designed and ...
(Date:11/25/2015)... November 25, 2015 Kitov Pharma ... (TASE: KTOV), a biopharmaceutical company focused on the development ... clinical conditions, today announced the closing of its previously ... ( ADSs ), each representing 20 ordinary shares of ... ADSs. The ADSs and warrants were issued in a ...
Breaking Medicine Technology: